UNQ HOLDINGS (02177) Plans to Acquire Japanese Consultative Pharmacy Chain Akahige Pharmacy for ¥2.701 Billion

Stock News
Dec 15, 2025

UNQ HOLDINGS (02177) announced that on December 15, 2025, its wholly-owned subsidiary, UNQ Japan Co., Ltd., intends to acquire a 90% stake in One Two Co., Ltd. for a total consideration of ¥2.701 billion. Upon completion, the target company will be indirectly held by UNQ HOLDINGS with approximately 90% ownership, making it an indirect non-wholly-owned subsidiary.

The target company is a limited liability company incorporated in Japan and operates Akahige Pharmacy, a leading consultative pharmacy chain specializing in sexual health and wellness. With over 33 years of market presence in Japan, Akahige Pharmacy operates more than nine locations across Hokkaido, Honshu, and Kyushu. Its core business focuses on providing personalized solutions for middle-aged and elderly men, addressing key sexual health concerns such as erectile dysfunction, premature ejaculation, and male menopause.

Beyond over-the-counter medications, Akahige Pharmacy has developed several patented sexual wellness products, including "Vigor King" and "Power Missile," aimed at supporting men's health and vitality.

UNQ HOLDINGS believes the acquisition will strengthen its foothold in Japan's pharmacy sector by leveraging Akahige Pharmacy's nationwide retail network. Additionally, the group expects synergies from the target company's established relationships with Japanese suppliers and logistics networks, aligning with its broader business strategy.

Post-acquisition, UNQ HOLDINGS plans to reassess and optimize the target company's financial position, potentially divesting non-core assets and reinvesting proceeds into new patented product development and brand expansion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10